Lewy bodies cannot be seen on an MRI scan. These abnormal protein clumps are microscopic, far too small for any current imaging technology to detect individually. They can only be identified under a microscope, which is why a definitive diagnosis of Lewy body dementia still requires examination of brain tissue after death. However, MRI can reveal indirect brain changes associated with Lewy body disease, and those patterns play a supporting role in diagnosis.
Why MRI Cannot Detect Lewy Bodies
Lewy bodies are tiny deposits of a misfolded protein called alpha-synuclein that accumulate inside nerve cells. They measure only about 5 to 25 micrometers across, roughly the width of a single cell. MRI works by detecting differences in water content and tissue density across relatively large areas of the brain. It simply does not have the resolution to pick up individual protein clumps at the cellular level.
Researchers have explored the idea of developing a radioactive tracer that could bind specifically to alpha-synuclein and light up on a PET scan, similar to how amyloid plaques can now be imaged in Alzheimer’s disease. But alpha-synuclein deposits tend to overlap with other misfolded proteins like tau and amyloid, making it extremely difficult to create a tracer that targets only Lewy body pathology. No reliable tracer exists yet.
What MRI Can Show Instead
Even though an MRI won’t reveal Lewy bodies themselves, it can show patterns of brain shrinkage that help distinguish Lewy body dementia from Alzheimer’s disease. The most useful pattern involves which brain regions are spared and which are not.
In Alzheimer’s, the hippocampus (the brain’s memory center) typically shrinks early and dramatically. In Lewy body dementia, the hippocampus tends to be relatively preserved. One review found that using medial temporal lobe preservation on MRI to differentiate Lewy body dementia from Alzheimer’s had a specificity of 94%, meaning that when the hippocampus looked relatively intact, it was a strong signal against Alzheimer’s. The catch is sensitivity: only about 40% of people with Lewy body dementia actually showed this distinguishing pattern on a standard scan, so a normal-looking MRI doesn’t rule the condition in or out.
The areas that do shrink more in Lewy body dementia are concentrated in the dorsal midbrain, a region deep in the brainstem involved in movement and alertness. One study found that midbrain gray matter density was significantly lower in people with Lewy body dementia than in those with Alzheimer’s, and that the degree of midbrain shrinkage correlated with cognitive decline. Smaller areas of volume loss also appear in the insula (involved in body awareness and emotion) and the hypothalamus.
Early Brain Changes Before Diagnosis
Research on people in the prodromal stage of Lewy body dementia, before full symptoms develop, has found subtle structural changes on MRI. These individuals often show widening of the brain’s grooves (sulci) in the frontal-insular, occipital, and olfactory regions. Thinning of the insular cortex is one of the earliest detectable changes, and it can appear even when memory-related structures like the hippocampus still look normal.
These findings are mostly detected through specialized research techniques like voxel-based morphometry, which uses software to compare brain volumes across groups. A standard clinical MRI report wouldn’t typically flag these subtle differences. Still, the pattern matters because it suggests that Lewy body disease affects smell-related and body-awareness brain regions early, which aligns with common early symptoms like loss of smell and fluctuating attention.
Neuromelanin-Sensitive MRI
A newer type of MRI sequence called neuromelanin-sensitive MRI offers a more targeted look at the brain regions Lewy body disease damages most. Neuromelanin is a dark pigment that builds up naturally in dopamine-producing and noradrenaline-producing neurons over a lifetime. It acts as a natural contrast agent, making these cell clusters visible on specially tuned MRI scans.
In healthy brains, these pigmented regions appear bright on the scan. In people with Lewy body diseases, the signal is diminished because the neurons containing neuromelanin have died off. Studies show that both the volume and brightness of these regions are reduced in Parkinson’s disease and Lewy body dementia compared to healthy controls, with good sensitivity and specificity. Post-mortem comparisons have confirmed that the MRI signal closely matches the actual number of surviving pigmented neurons. This technique is still primarily a research tool, but it represents one of the more promising ways MRI might contribute to earlier, more accurate diagnosis.
How MRI Compares to DaTscan
When doctors suspect Lewy body dementia, the imaging test with the strongest diagnostic track record is a DaTscan, not an MRI. A DaTscan uses a small amount of radioactive tracer to measure dopamine transporter activity in the brain. Because Lewy body disease destroys dopamine-producing neurons, a DaTscan can detect this loss directly.
In one autopsy-verified study of 33 probable Lewy body dementia cases and 22 Alzheimer’s cases, the DaTscan achieved 80% sensitivity and 92% specificity for identifying Lewy body disease. Clinical diagnosis alone, without the scan, managed 87% sensitivity but only 72% specificity, meaning doctors were more likely to incorrectly label someone with Lewy body dementia when relying on symptoms alone. An earlier review of a single autopsy-verified study reported even higher numbers: 100% sensitivity and 92% specificity for DaTscan.
MRI’s sensitivity of around 40% is substantially lower, which is why it is not used as the primary diagnostic tool for Lewy body dementia. Its main clinical purpose when Lewy body disease is suspected is to rule out other causes of cognitive decline, such as strokes, tumors, or normal pressure hydrocephalus, and to look for atrophy patterns that might point toward or away from Alzheimer’s disease.
What to Expect if You’re Getting an MRI
If you or a family member is being evaluated for possible Lewy body dementia, an MRI is a routine part of the workup, but it’s important to understand what it can and can’t do. The scan will give your medical team a detailed picture of brain structure. It can identify whether there’s significant hippocampal shrinkage (pointing more toward Alzheimer’s), vascular damage from small strokes, or other structural problems that could explain symptoms.
A “normal” MRI does not mean there is no Lewy body disease. The structural changes in Lewy body dementia are often subtle and may not stand out on a standard clinical read. If Lewy body dementia remains suspected, additional tests like a DaTscan, a sleep study to check for REM sleep behavior disorder, or cognitive testing typically follow. The diagnosis ultimately comes together from the full clinical picture: symptoms like visual hallucinations, fluctuating alertness, movement problems, and sleep disturbances, supported by whatever imaging and lab results are available.